News and Insights of 3D Printing and Manufacturing
Fluicell, a Sweden-based bioprinting startup founded in 2012 as a spin-out of the Chalmers University of Technology, has undertaken research to develop medicinal products for treating type 1 diabetes. The project, which recently achieved a significant milestone, is based on biocomposite tissues generated by Fluicell’s Biopixlar system.
restor3d merger with Kinos Medical, an expert total ankle replacement company. restor3d was founded with a mission to enable surgeons to repair and reconstruct the human body using 3D printing technologies, advanced biomaterials, and artificial intelligence. In 2018, the company invested in significant infrastructure and in-house manufacturing capabilities to expand its offering of implants in orthopedic and spine indications. With a robust pipeline of products slated for regulatory submission, recent FDA clearances include osteotomy wedges and cervical interbody fusion implants. The merger with Kinos Medical will accelerate restor3d’s expansion into the high-growth foot and ankle market in the U.S.
3D printer manufacturer 3D Systems has announced a co-development agreement with CollPlant, a regenerative medicine firm, to develop 3D bioprinted soft tissue structures for breast reconstruction treatments.
A group of Korean scientists have developed a low-cost 3D printed adapter that turns everyday smartphones into endoscopic vocal cord disease diagnostic tools.
3D LifePrints, a leading 3D technology company providing innovative solutions to the medical sector, has achieved ISO 13485:2016 certification for its Quality Management System (QMS).
Aetrex Worldwide launched Albert 3DFit, a sleek and modern 3D foot scanner created to revolutionize the retail industry by making 3D fit technology available to stores of all sizes. Offering the most innovative technologies, this scanner can calculate customers’ 3D foot measurements in less than 10 seconds with an accuracy of up to 1 millimeter. It features Aetrex’s FitGenius AI platform, which matches customers’ unique foot profiles with their ideal footwear styles and sizes to provide personalized footwear recommendations that can be accessed across a retailer’s digital shopping platforms after leaving the store.
Advanced Development of Additive Manufacturing (A.D.A.M.) is on the cusp of releasing 3D-printed bioresorbable bone implants. The implants would, if successful, be completely absorbed by the body. Recovery times would improve; patients would undergo fewer surgeries; the implant is personalized to each patient.
Population aging is one of Europe’s great challenges in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic joint detop fects or defects in the oral and maxillofacial regions have a significantly reduced quality of life and are continually dependent on health care. The Covid-19 crisis has shown how dangerous chronically overcrowded hospitals and large cohorts of care-dependent and risk-grouped patients can become. Therefore, science and technology must work together to ensure that living longer can be synonymous with living well. INKplant, a project funded by the European Union H2020, was conceived to face this challenge and democratize its new solutions.
Engineers from McMaster University in Hamilton, Canada, have developed a 3D bioprinting method using magnets to rapidly produce cell clusters.
Researchers from the Massachusetts Institute of Technology (MIT) have used fine-scale 3D bioprinting and melt electrowriting to grow highly uniform cell cultures.